« Back to Record
Citation APA

Pappas, P. P., Vazquez, J. J., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Roca, R. F., Mccarty, T., Thompson, G. G., Schlamm, H., Bien, P. P., Barbat, S. S., Wedel, P., Oborska, I., Tawadrous, M., & Hodges, M. (2023). Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial. Journal of antimicrobial chemotherapy, 78(10), 2471-2480. doi:10.1093/jac/dkad256


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/372479

Pappas, P. P., Vazquez, J. J., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Roca, R. F., Mccarty, T., Thompson, G. G., Schlamm, H., Bien, P. P., Barbat, S. S., Wedel, P., Oborska, I., Tawadrous, M., & Hodges, M. (2023). Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial. Journal of antimicrobial chemotherapy, 78(10), 2471-2480. doi:10.1093/jac/dkad256